Illumina forms 15-year cancer sequencing deal with Roche
Separately, the next-generation sequencing manufacturer will also work with Genomics England to sequence up to 300,000 people over the next five years.
Separately, the next-generation sequencing manufacturer will also work with Genomics England to sequence up to 300,000 people over the next five years.